Samra Turajlic

Midland Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 144 publications

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

Journal: European urology open science

Published: June 17, 2026

Beyond the Primary Tumour: Rethinking Biomarker Strategies in Recurrent Renal Cell Carcinoma.

Beyond the Primary Tumour: Rethinking Biomarker Strategies in Recurrent Renal Cell Carcinoma.

Journal: European urology

Published: May 25, 2026

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Journal: Nature

Published: January 14, 2026

Expression of Concern: Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma.

Expression of Concern: Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma.

Journal: Cancer discovery

Published: December 18, 2025

Advanced imaging of immune cells for human kidney disease.

Advanced imaging of immune cells for human kidney disease.

Journal: Trends in molecular medicine

Published: December 09, 2025

Immunometabolic Gatekeeping: Reconciling Peto's & the T-cell Infiltration Prognostic Paradox.

Immunometabolic Gatekeeping: Reconciling Peto's & the T-cell Infiltration Prognostic Paradox.

Journal: ArXiv

Published: December 08, 2025

Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials.

Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials.

Journal: European urology open science

Published: December 05, 2025

Immunometabolic gatekeeping: How tissue metabolism conditions tumor immunity.

Immunometabolic gatekeeping: How tissue metabolism conditions tumor immunity.

Journal: Cancer cell

Published: November 22, 2025

Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial.

Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial.

Journal: Nature communications

Published: October 23, 2025

Publisher Correction: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function.

Publisher Correction: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function.

Journal: Nature

Published: September 16, 2025

Uveal Melanoma UK national guidelines: 2023 update.

Uveal Melanoma UK national guidelines: 2023 update.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 11, 2025

Contrasting Features of Papillary and Chromophobe Renal Cell Carcinoma Revealed by Whole-Genome Sequencing.

Contrasting Features of Papillary and Chromophobe Renal Cell Carcinoma Revealed by Whole-Genome Sequencing.

Journal: Molecular cancer research : MCR

Published: June 10, 2025

Showing 1-12 of 144

Last Updated: 09/26/2026